Well, I've been expecting it and it appears that it's here. The market put up one of its best months ever in April, but starting on Thursday my anticipated end of the rally kicked off. I'm saying it here...
CoronaVirus is not only the buzzword for the whole market both on the negative side as business falls off a cliff, and positively as some companies look for a cure. It seems like most everyone in healthcare is looking...
While the markets may not have had the most volatile week of the year, nor come close, it was a very topsy-turvy five days for Tailwinds. A couple stocks up over 30% and a couple down over 50%. Meanwhile,...
Tailwinds' Take: being able to distinguish men who are disease free could dramatically reduce the number of unnecessary biopsies performed annually, resulting in both fewer painful surgeries for patients and large savings for the medical system. SAN JOSE, Calif., April...
Tailwinds' Take: this is very interesting news. We have long stated our respect for Dr. Kumar. His ability to think outside the box is phenomenal and this program, with OntoChem demonstrates that thinking. OntoChem has the largest database of...

IF Alpha?

My biggest concern last fall was, "what if Bernie gets into office?" This fear was driven partially by the fact that the market would likely sell off with the democratic socialist in charge, but more so by the concern...
My Take on The Market This was a good week in the market, which was a welcome relief. We had a big bailout announced by the federal government and some estimates of how bad COVID19 could be came down a...
Sometimes a typo can hit the sweet spot, right? When I got the text that we're entering a beer market...well, let's just say that I couldn't have agreed more. Stocks are in free-fall, the country is entering a national...
Vaccines seem to be all the rage these days. Well, at least ones related to the CoronaVirus. If you are somehow associated with the development of a COVID-19 vaccine or cure, your stock is strong and life’s good. If...
SAN JOSE, Calif., March 2, 2020 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against cancer, today announced that data related to Anixa's recently launched Cchek™ Prostate Cancer...
DFC Advisory Services LLC (dba Tailwinds Research) is a registered investment adviser. Information presented is for educational purposes only and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Investments involve risk and unless otherwise stated, are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Past performance is not indicative of future performance.